New AD drug
Kurt A. Kistler
kistler at a.chem.upenn.edu
Thu Jun 16 21:45:34 EST 1994
Dag Stenberg (stenberg at cc.Helsinki.FI) wrote:
: Kurt A. Kistler (kistler at a.chem.upenn.edu) wrote:
: > Does anyone know anything about the new AD drug that is going through clinical
: > trials right now? It's called something like Salbelusol, and the short radio
: > report on it stated it was not a AChE inhibitor.
: Salb... suggests something different, but I would have suspected that a
: new drug in clinical trials would be tacrine.
: Tacrine just got prohibited in Sweden, and no more clinical trials
: will be allowed. This might interest some people...
I believe Tacrine is on the U.S. market now, even though it does not
do such a great job. Are AChE inhibitors a waste of time?
\\ || // | Kurt A. Kistler
\\||// | University of Pennsylvania
//||\\ The way of water. | Department of Chemistry
// || \\ | kistler at a.chem.upenn.edu
// \|| \\ |
More information about the Neur-sci